Schedule at a Glance

MONDAY, SEPTEMBER 18

7:00

REGISTRATION & BREAKFAST

 

 

8:30

 

8:45

 

9:15

 

9:45​

INAUGURAL SESSION

Session Chair – Ritu Aneja, PhD

Welcome Remarks  James Weyhenmeyer, PhD , Vice President for Research and Economic Development, Georgia State University, USA

Inaugural Address  Ian O. Ellis, MD, FRCPath, University of Nottingham, UK, Triple Negative Breast Cancer: A Pathologists Perspective

Keynote Talk  Charles M. Perou, PhD, University of North Carolina – Chapel Hill, USA, Triple Negative Breast Cancer: Biology and Heterogeneity

LaToya Johnson, TNBC Survivor

10:00

COFFEE BREAK

 

 

10:45

11:15

11:45

SESSION 1 : Predictive & Prognostic Biomarkers

Session Chair – Ian O. Ellis, FRCPath 

Maria Foschini, MD – University of Bologna, Italy, Morphological and Molecular Features of TNBC

Christos Hatzis, PhD – Yale Cancer Center, USA, Genomic Heterogeneity of Triple Negative Breast Cancer and its Effect on Patient Selection

Brian D. Lehmann, PhD – Vanderbilt University, USA, Molecular Heterogeneity of Triple Negative Breast Cancer     

12:15

LUNCH

 

 

1:30

2:00

2:30

SESSION 2 : The Biology of TNBC

Session Chair – Vimla Band, PhD 

Zsuzsanna Varga, MD – University of Zurich, Switzerland, Tumor Microenvironment and TNBC Prognosis

Grace Callagy, MD, PhD – National University of Ireland – Galway, Ireland, Exploring Outcomes for Triple Negative Breast Cancer in an Irish Cohort

Emiel A. Janssen, PhD – University of Stavanger, Norway, MicroRNAs as Biomarkers for TNBC

3:00

COFFEE BREAK

 

 

3:15

 

3:45

 

4:15

SESSION 3 : Novel Therapeutic Targets & Treatments

Session Chair – Amelia Zelnack, MD, MSc 

Tiffany A. Traina, MD – Memorial Sloan Kettering Cancer Center, USA, Targeting the Androgen Receptor in TNBC 

Ruth O’Regan, MD – University of Wisconsin – Madison, USA, Emerging Targeted Therapies for Metastatic TNBC

Antonio C. Wolff, MD – Johns Hopkins University, USA, Clinical Trial Strategies for Early Stage TNBC

6:30

DINNER FOR ALL ATTENDEES

Wednesday, September 20

Wednesday will include a half-day of collaboration, networking, and events open to active ICART member researchers who have contributed resources, samples, and/or datasets. Additional details are forthcoming.​